Research Article
Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy
Table 2
Comparison of effective data of chemotherapy plus TFS and chemotherapy without TFS.
| | Treatment line | Whether to add TFS | N | Efficacy data (n, %) | ORR (%) | P(χ2) | DCR (%) | P(χ2) | | CR | PR | SD | PD |
| | First- line | Without TFS | 42 | 1(2.38) | 12(28.57) | 15(35.71) | 14(33.33) | 30.95 | 0.756(0.097) | 66.66 | 0.494(0.468) | | Add TFS | 38 | 2(5.26) | 11(28.95) | 15(39.47) | 10(26.32) | 34.21 | 73.68 | | Recurrent | Without TFS | 58 | 0(0) | 13(22.41) | 23(39.66) | 22(37.93) | 22.41 | 0.624(0.241) | 62.07 | 0.519(0.417) | | Add TFS | 53 | 0(0) | 14(26.42) | 22(41.51) | 17(32.08) | 26.42 | 67.93 |
|
|
